Meeting Timetable
| Thursday, September 19, 2024 | |||
| Hall A IACH |
|||
| 08:30-09:00 | Welcome Coffee | ||
| 09:00-10:20 | Transplant Workshop Part I Supported by an unrestricted eduational grant from Sanofi |
||
| 10:20-10:30 | Short Break | ||
| 10:30-12:00 | Transplant Workshop Part II | ||
| 12:00-12:45 | Lunch Break | ||
| Hall A IACH + COLYM |
Hall B COMydAL + MPNCo&D |
||
| 12:45-13:00 | Meeting Opening Message |
||
| 13:00-14:30 | Session 1a: Indolent lymphoma |
Session 1b: Controversies in lower risk MDS |
|
| 14:30-14:50 | Coffee Break | ||
| 14:50-15:20 | Essential thrombocythemia: Unmet needs and impact of novel therapies Meet the Expert Session supported by MSD |
||
| 15:20-15:30 | Coffee Break continued … | ||
| 15:30-17:00 | Session 2a: Hodgkin lymphoma |
Session 2b: Treatment of intermediate/higher-risk MF |
|
| 17:00-17:10 | Technical Break | ||
| 17:10-18:40 | Session 3a: Diffuse large B cell lymphoma (DLBCL) |
Session 3b: Controversies in higher risk MDS |
|
| 18:40 | Meeting Welcome Reception | ||
| Friday, September 20, 2024 | |||
| Hall A IACH + COLYM |
Hall B COMydAL + MPNCo&D |
||
| 08:15-08:30 | Welcome Coffee | ||
| 08:30-10:00 | IACH Session: Sexual and emotional life in patients with hematological malignancies | ||
| 10:00-10:30 | Keynote IACH Lecture | ||
| 10:30-11:00 | Coffee Break | ||
| 11:00-12:30 | Session 4a: T cell non-Hodgkin lymphoma (T-NHL) |
Session 4b: Essential thrombocytosis (ET) in 2024: Current and future directions |
|
| 12:30-13:00 | IACH Awards | ||
| 13:00-13:45 | Lunch Break | ||
| 13:45-14:45 | Charting Horizons: Advancing Care for Relapsed/Refractory Mantel Cell Lymphoma Patients Lunch Symposium supported by Lilly |
||
| 14:45-15:00 | Technical Break | ||
| 15:00-16:30 | Session 5a: Chronic lymphocytic leukemia (CLL) |
Session 5b: Controversies in classification, risk stratification and response assessment in AML |
|
| 16:30-17:00 | Coffee Break | ||
| 17:00-18:30 | Session 6a: Minimal residual disease (MRD) |
Session 6b: MPN special situations and future directions |
|
| Saturday, September 21, 2024 | ||
| Hall A IACH + COLYM |
Hall B COMydAL + MPNCo&D |
|
| 08:15-08:30 | Welcome Coffee | |
| 08:30-10:00 | Session 7a: Mantle cell lymphoma (MCL) |
Session 7b: Controversies in the management of AML |
| 10:00-10:30 | Coffee Break | |
| 10:30-12:00 | IACH Session: Management of hard-to-treat patients |
|
| Jazz Pharmaceuticals has provided financial support for this session but has had no involvement in any aspect of this activity, including, but not limited to, the selection, development, content or organisation of this session. | ||
| 12:00-12:45 | Lunch Break | |
| 12:45-14:15 | Session 8a: Rare diseases |
Session 8b: A new era of disease modificiaton for polycythemia vera (PV) |
| 14:15-15:45 | IACH Lectures |
|
| 15:45-16:00 | Meeting Closing Remarks | |